2012
DOI: 10.1523/jneurosci.6202-11.2012
|View full text |Cite
|
Sign up to set email alerts
|

GluN2D Subunit-Containing NMDA Receptors Control Tissue Plasminogen Activator-Mediated Spatial Memory

Abstract: Tissue plasminogen activator (tPA) is a serine protease with pleiotropic actions in the CNS, such as synaptic plasticity and neuronal death. Some effects of tPA require its interaction with the GluN1 subunit of the NMDA receptor (NMDAR), leading to a potentiation of NMDAR signaling. We have reported previously that the pro-neurotoxic effect of tPA is mediated through GluN2D subunit-containing NMDARs. Thus, the aim of the present study was to determine whether GluN2D subunit-containing NMDARs drive tPA-mediated… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
14
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 47 publications
(95 reference statements)
2
14
0
Order By: Relevance
“…By increasing the surface dynamics of a fraction of extrasynaptic NMDAR, we can propose that cumulative effects in the whole population of NMDARs are responsible for the potentiating effect of tPA on NMDARs signaling. These observations fit with our previous finding that tPA-promoted neurotoxicity through a mechanism that involved extrasynaptic and possibly GluN2D-containing NMDARs, 35, 44 a phenomenon also associated with an activation of the ERK(½) pathway. 35 In this study, we show that Glunomab is also capable to prevent the tPA-dependent increase of neuronal ERK(½) activation.…”
Section: Discussionsupporting
confidence: 92%
“…By increasing the surface dynamics of a fraction of extrasynaptic NMDAR, we can propose that cumulative effects in the whole population of NMDARs are responsible for the potentiating effect of tPA on NMDARs signaling. These observations fit with our previous finding that tPA-promoted neurotoxicity through a mechanism that involved extrasynaptic and possibly GluN2D-containing NMDARs, 35, 44 a phenomenon also associated with an activation of the ERK(½) pathway. 35 In this study, we show that Glunomab is also capable to prevent the tPA-dependent increase of neuronal ERK(½) activation.…”
Section: Discussionsupporting
confidence: 92%
“…GluN2C and GluN2D) in the frontal cortex and hippocampus of eNRG1-treated mice, which can be involved in the hypersensitivity to MK-801. The specificity of the anti-GluN2D antibody, but not that for the anti-GluN2C antibody, has been verified with the use of knockout mice [ 39 , 40 ] Although the molecular nature of the present GluN2C-like immunoreactivity required further validation, the above arguments are in agreement with the observation that NMDA receptor-hypomorphic mutant mice show hypersensitivity to an NMDA receptor blocker [ 24 , 41 ]. Recently, Belforte et al (2010) also provide supportive evidence that the psychomimetric activity of MK-801 is ascribed to a decrease in the NMDA receptor sensitivity of parvalbumin-positive GABA neurons during postnatal development [ 42 ].…”
Section: Discussionmentioning
confidence: 73%
“…Grin2c but not Grin2d or Grin2b subunits mediated both mPFC-evoked HA-NMDAR currents in vitro and quinine-resistant alcohol intake. Little is otherwise known about the behavioral functions of Grin2c and Grin2d, although alcohol intake decreases Grin2c striatal mRNA 47 and Grin2d is implicated in acute drug responses 48 and spatial memory 49 . Adult striatum has very little Grin2c and Grin2d 50 , and these subunits have not been detectable in total brain tissue (data not shown).…”
Section: Discussionmentioning
confidence: 99%